General Information
Drug ID
DR00569
Drug Name
Glycocholic acid
Synonyms
Glycocholate; cholylglycine
Drug Type
Small molecular drug
Indication Bile acid synthesis defect [ICD11: 5C52.11] Phase 3 [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=10140"></iframe>
3D MOL 2D MOL
Formula
C26H43NO6
Canonical SMILES
CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C
InChI
InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1
InChIKey
RFDAIACWWDREDC-FRVQLJSFSA-N
CAS Number
CAS 475-31-0
Pharmaceutical Properties Molecular Weight 465.631 Topological Polar Surface Area 127
Heavy Atom Count 33 Rotatable Bond Count 6
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 6
PubChem CID
10140
PubChem SID
10321717 , 103578964 , 103914204 , 104322487 , 111677790 , 11466549 , 11467669 , 11486158 , 121363138 , 124799639 , 126677625 , 134973317 , 135859566 , 136380477 , 137006903 , 141721990 , 143839380 , 144212866 , 152104461 , 160854679 , 162180900 , 17422069 , 25631010 , 29204189 , 29228672 , 4266392 , 47515514 , 47810956 , 47810957 , 48035333 , 48334701 , 49698538 , 49747593 , 50070579 , 50071192 , 50111368 , 5027 , 53790906 , 56416996 , 56463222 , 57325988 , 77551091 , 7887780 , 8145498 , 8157310 , 838311 , 841388 , 85787509 , 92125467 , 93167178
ChEBI ID
CHEBI:17687
TTD Drug ID
D08WQV
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [3]
MRP3 Transporter Info Multidrug resistance-associated protein 3 Substrate [4]
MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [5]
OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [6]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [7]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [6]
References
1 ClinicalTrials.gov (NCT01589523) GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
2 Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta. Mol Pharmacol. 2012 Feb;81(2):273-83.
3 Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J Biol Chem. 2003 Jun 27;278(26):23529-37.
4 Measurement of transport activities of bile acids in human multidrug resistance-associated protein 3 using liquid chromatography-tandem mass spectrometry. Anal Sci. 2010;26(3):317-23.
5 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
6 Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.
7 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.